Generalized morphea

Dermatology Online Journal

Volumn 9, Issue 4, 2003, Pages 83-85

  Strober, Bruce E ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCIPOTRIOL; DOXYCYCLINE; GLUCOCORTICOID;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; SCLERODERMA;

EID: 3042662805     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Tuffanelli, DL. Localized scleroderma. Semin Cutan Med Surg 1998;17:27
2. Falanga, V, Medsger, TA. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 1987;123:350
3. Falanga, V, et al. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. J Am Acad Dermatol 1987;17:648
4. Weide, B, et al. Is morphoea caused by Borrelia burgdorferi? A review. Br J Dermatol 2000;142:636
5. Falanga V, et al. D-penicillamine in the treatment of localized scleroderma. Arch Dermatol 1990;126:609
6. Hulshof MM, et al. Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol 1994;130:1290
7. Kerscher, M, et al. Low-dose phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998;38:21
8. Seyger, MMB, et al. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol 1998;39:220